Imperial College London

ProfessorRobinShattock

Faculty of MedicineDepartment of Infectious Disease

Chair in Mucosal Infection and Immunity
 
 
 
//

Contact

 

+44 (0)20 7594 5206r.shattock

 
 
//

Location

 

453Wright Fleming WingSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Joseph:2016,
author = {Joseph, S and Quinn, K and Greenwood, A and Miller, A and Cope, AV and Mckay, PF and Hayes, P and Kopycinski, J and Bouliotis, G and Gilmour, J and McFarlane, L and Tatoud, R and Shattock, RJ and Lewis, D and Montefiore, D and Esteban, M and Wagner, R and McCormack, S and Weber, J},
pages = {99--99},
publisher = {MARY ANN LIEBERT, INC},
title = {UK HVC 003: A Phase I Clinical Trial Exploring a Strategy to Maximise HIV Antibody Responses using Subtype C DNA, MVA and GLA Adjuvanted gp140},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386774600176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Joseph,S
AU - Quinn,K
AU - Greenwood,A
AU - Miller,A
AU - Cope,AV
AU - Mckay,PF
AU - Hayes,P
AU - Kopycinski,J
AU - Bouliotis,G
AU - Gilmour,J
AU - McFarlane,L
AU - Tatoud,R
AU - Shattock,RJ
AU - Lewis,D
AU - Montefiore,D
AU - Esteban,M
AU - Wagner,R
AU - McCormack,S
AU - Weber,J
EP - 99
PB - MARY ANN LIEBERT, INC
PY - 2016///
SN - 0889-2229
SP - 99
TI - UK HVC 003: A Phase I Clinical Trial Exploring a Strategy to Maximise HIV Antibody Responses using Subtype C DNA, MVA and GLA Adjuvanted gp140
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386774600176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -